annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companyâs Chief Executive Officer, will present at upcoming investor conferences in May.
Citi Biopharma Virtual Co-Panel Day Date: Wednesday, May 18, 2022 4:30 pm ET (6:30 am AET)
H.C. Wainwright Annual Global Life Sciences...
>>> Read more: Opthea To Present at Upcoming Investor Conferences
MELBOURNE, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companyâs Chief Executive Officer, will present at upcoming investor conferences in May.
Citi Biopharma Virtual Co-Panel Day Date: Wednesday, May 18, 2022 4:30 pm ET (6:30 am AET)
H.C. Wainwright Annual Global Life Sciences...
>>> Read more: Opthea To Present at Upcoming Investor Conferences
